Halo Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.9M

  • Investors
  • 5

Halo Therapeutics General Information

Description

Developer of small molecule therapeutics designed to target metabolic conditions through novel receptor modulation. The company offers scaffold-selective GPCR modulators and gut-targeted ligand approaches that activate alternative signaling pathways, enabling pharmaceutical and biotechnology organizations to develop treatments that enhance endogenous hormone secretion and improve metabolic regulation.

Contact Information

Website
www.halo-therapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ty Merlin Caerphilly Business Park
  • Van Road
  • Caerphilly CF83 3GS
  • Wales, United Kingdom
+44 07907
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • Ty Merlin Caerphilly Business Park
  • Van Road
  • Caerphilly CF83 3GS
  • Wales, United Kingdom
+44 07907

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Halo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 17-May-2023 $1.9M Completed Pre-Clinical Trials
2. Angel (individual) 29-Jan-2021 Completed Startup
1. University Spin-Out 14-Dec-2020 Completed Startup
To view Halo Therapeutics’s complete valuation and funding history, request access »

Halo Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred A Ordinary
Ordinary
Ordinary 262,487 $0.000125 $2.25 $2.25 1x $2.25 11.81%
To view Halo Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Halo Therapeutics Patents

  • 18

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

Halo Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020472970-A1 Agonists of free fatty acid receptor 1 and their use in diseases associated with said receptor Pending 20-Oct-2020
CA-3196009-A1 Agonists of free fatty acid receptor 1 and their use in diseases associated with said receptor Pending 20-Oct-2020
EP-4232448-A1 Agonists of free fatty acid receptor 1 and their use in diseases associated with said receptor Active 20-Oct-2020
EP-4232448-B1 Agonists of free fatty acid receptor 1 and their use in diseases associated with said receptor Active 20-Oct-2020
EP-4232448-C0 Agonists of free fatty acid receptor 1 and their use in diseases associated with said receptor Active 20-Oct-2020 C07D413/12
To view Halo Therapeutics’s complete patent history, request access »

Halo Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Halo Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Development Bank of Wales Growth/Expansion Minority
Empirical Ventures Venture Capital Minority
KBA Group Angel Group Angel Group Minority
Science Angel Syndicate Angel Group Minority
University of Bristol University
To view Halo Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Halo Therapeutics FAQs

  • When was Halo Therapeutics founded?

    Halo Therapeutics was founded in 2020.

  • Where is Halo Therapeutics headquartered?

    Halo Therapeutics is headquartered in Caerphilly, United Kingdom.

  • What is the size of Halo Therapeutics?

    Halo Therapeutics has 6 total employees.

  • What industry is Halo Therapeutics in?

    Halo Therapeutics’s primary industry is Drug Discovery.

  • Is Halo Therapeutics a private or public company?

    Halo Therapeutics is a Private company.

  • What is the current valuation of Halo Therapeutics?

    The current valuation of Halo Therapeutics is .

  • What is Halo Therapeutics’s current revenue?

    The current revenue for Halo Therapeutics is .

  • How much funding has Halo Therapeutics raised over time?

    Halo Therapeutics has raised $2.55M.

  • Who are Halo Therapeutics’s investors?

    Development Bank of Wales, Empirical Ventures, KBA Group Angel Group, Science Angel Syndicate, and University of Bristol have invested in Halo Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process